Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Cardiovasc Intervent Radiol ; 40(3): 460-464, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27864609

ABSTRACT

Bronchial artery embolization is now a common treatment for massive pulmonary hemoptysis if flexible bronchoscopy at the bedside failed to control the bleeding. Complications of this technique range from benign chest pain to devastating neurological impairments. We report the case of a 41-year-old man who developed an ST elevation myocardial infarction during bronchial artery embolization, presumably because of coronary embolism by injected particles. In this patient who had no previously known coronary artery disease, we retrospectively found a communication between the left bronchial artery and the circumflex coronary artery. This fistula was not visible on the initial angiographic view and likely opened because of the hemodynamic changes resulting from the embolization. This case advocates for careful search for bronchial-to-coronary arterial fistulas and the need for repeated angiographic views during embolization procedures.


Subject(s)
Bronchial Arteries , Coronary Stenosis/etiology , Embolization, Therapeutic/adverse effects , Embolization, Therapeutic/methods , Hemoptysis/therapy , ST Elevation Myocardial Infarction/etiology , Angiography , Bronchial Arteries/diagnostic imaging , Bronchoscopy , Coronary Stenosis/diagnostic imaging , Echocardiography , Humans , Male , Middle Aged , Retrospective Studies , ST Elevation Myocardial Infarction/diagnostic imaging
4.
BMC Health Serv Res ; 15: 106, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25880097

ABSTRACT

BACKGROUND: Quick reversal of warfarin anticoagulation is important in life threatening bleeding. The aim of this study is to improve the administration delay when using Prothrombin Complex Concentrate (PCC) for the emergent reversal of warfarin anticoagulation in the emergency department. METHODS: An audit and feedback quality improvement project was conducted in three phases: a retrospective audit phase, an analysis and feedback phase and prospective evaluation phase. The charts of all eligible patients in a single Emergency Department (ED) in Québec, Canada, who received PCC since the introduction of this product in 2009 until October 31, 2011, were retrospectively audited. The administration delay of PCC was calculated from the time of prescription to the time of administration. With the data, we determined where improvements could be attained, and jointly with all stakeholders in the ED and the blood bank, we created an action plan to ensure the timely administration of PCC. The action plan was then implemented and a six-month prospective evaluation study was conducted to determine any improvement. RESULTS: Seventy-seven charts were reviewed in the retrospective chart audit. The mean administration delay was 73.6 minutes (STD [34.1]) with a median of 70.0 minutes (25-75% IQR [45.0-95.0]). We found that this delay was principally due to the following barriers: communication problems between the ED and the blood bank as well as delivery inefficiencies. An action plan that involved a flowchart to remind all clinicians how to order PCC and a new delivery method from the blood bank to the ED were developed. During the 6 months following the implementation of our action plan, 39 patients received PCC and the mean administration time decreased to 33.2 minutes (STD [14.2])(p < .0001) with a median of 30.0 minutes (25-75% IQR [24.3-38.8]). CONCLUSION: By implementing an action plan comprising of a flowchart and a new delivery process, this audit and feedback quality improvement project reduced the administration time of PCC by more than half. Future studies to measure the impact of a similar audit and feedback process involving an action plan in other centers should be conducted before this type of quality improvement process is implemented on wider scale.


Subject(s)
Antifibrinolytic Agents/administration & dosage , Blood Coagulation Factors/administration & dosage , Emergency Medical Services/standards , Hemorrhage/drug therapy , Hemorrhage/prevention & control , Practice Guidelines as Topic , Quality Improvement/standards , Aged , Aged, 80 and over , Anticoagulants/adverse effects , Drug Administration Schedule , Female , Hemorrhage/etiology , Humans , Male , Prospective Studies , Quebec , Retrospective Studies , Time Factors , Warfarin/adverse effects
5.
Emerg Med J ; 30(3): 251-2, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23413306

ABSTRACT

A short-cut review was carried out to establish whether CT pulmonary angiography (CTPA) or ventilation-perfusion (VQ) scanning offer advantages in imaging the pregnant woman with a possible deep vein thrombosis. A total of 80 papers was found using the reported search, of which four represented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. The clinical bottom line is that a ventilation-perfusion (or perfusion) scan should be prioritised if the chest x-ray is normal. In the case of an abnormal chest x-ray, a CT pulmonary angiography scan will be better in finding an alternative diagnosis.


Subject(s)
Evidence-Based Emergency Medicine , Pregnancy Complications, Cardiovascular/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Tomography, X-Ray Computed , Diagnosis, Differential , Female , Humans , Pregnancy , Radionuclide Imaging , Ventilation-Perfusion Ratio
SELECTION OF CITATIONS
SEARCH DETAIL
...